Online citations, reference lists, and bibliographies.
← Back to Search

Current State Of A Dual Behaviour Of Antimicrobial Peptides—Therapeutic Agents And Promising Delivery Vectors

U. Piotrowska, M. Sobczak, E. Oledzka
Published 2017 · Biology, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Micro‐organism resistance is an important challenge in modern medicine due to the global uncontrolled use of antibiotics. Natural and synthetic antimicrobial peptides (AMPs) symbolize a new family of antibiotics, which have stimulated research and clinical interest as new therapeutic options for infections. They represent one of the most promising antimicrobial substances, due to their broad spectrum of biological activity, against bacteria, fungi, protozoa, viruses, yeast and even tumour cells. Besides, being antimicrobial, AMPs have been shown to bind and neutralize bacterial endotoxins, as well as possess immunomodulatory, anti‐inflammatory, wound‐healing, angiogenic and antitumour properties. In contrast to conventional antibiotics, which have very defined and specific molecular targets, host cationic peptides show varying, complex and very rapid mechanisms of actions that make it difficult to form an effective antimicrobial defence. Importantly, AMPs display their antimicrobial activity at micromolar concentrations or less. To do this, many peptide‐based drugs are commercially available for the treatment of numerous diseases, such as hepatitis C, myeloma, skin infections and diabetes. Herein, we present an overview of the general mechanism of AMPs action, along with recent developments regarding carriers of AMPs and their potential applications in medical fields.
This paper references
10.1016/j.jconrel.2016.03.025
Reduced cytotoxicity and enhanced bioactivity of cationic antimicrobial peptides liposomes in cell cultures and 3D epidermis model against HSV.
Sapir Ron-Doitch (2016)
10.1016/j.jcis.2016.05.002
Membrane interactions of mesoporous silica nanoparticles as carriers of antimicrobial peptides.
Katharina Braun (2016)
10.1371/journal.pone.0095939
Antimicrobial and Immunomodulatory Activities of PR-39 Derived Peptides
E. Veldhuizen (2014)
Biomed
Y. Chen (2014)
10.1016/j.biomaterials.2010.08.035
Antimicrobial peptides on calcium phosphate-coated titanium for the prevention of implant-associated infections.
Mehdi Kazemzadeh-Narbat (2010)
10.1042/BSR20090104
Celecoxib-loaded liposomes: effect of cholesterol on encapsulation and in vitro release characteristics.
Asli Deniz (2010)
10.1007/s10856-014-5363-5
Nanomechanical mapping of bone tissue regenerated by magnetic scaffolds
M. Bianchi (2015)
10.1007/s11095-007-9274-8
Stability of Antimicrobial Decapeptide (KSL) and Its Analogues for Delivery in the Oral Cavity
Dong Hee Na (2007)
Antimicrob
M. Vaaraand (1996)
10.1128/AAC.00143-14
Efficacy of the Novel Topical Antimicrobial Agent PXL150 in a Mouse Model of Surgical Site Infections
J. Håkansson (2014)
10.3390/molecules21020158
Design and Characterization of a Novel p1025 Peptide-Loaded Liquid Crystalline System for the Treatment of Dental Caries
G. Calixto (2016)
10.1016/j.foodchem.2015.04.136
Adsorption of nisin and pediocin on nanoclays.
S. M. M. Meira (2015)
10.1016/j.ijpharm.2015.08.037
The consideration of indolicidin modification to balance its hemocompatibility and delivery efficiency.
C. Tsai (2015)
10.1093/JAC/43.2.203
Antimicrobial properties of liposomal polymyxin B.
S. McAllister (1999)
10.1016/j.jconrel.2016.05.064
Delivery of LLKKK18 loaded into self-assembling hyaluronic acid nanogel for tuberculosis treatment.
J. Silva (2016)
10.1371/journal.pone.0106766
Synergistic Anti-Inflammatory Activity of the Antimicrobial Peptides Human Beta-Defensin-3 (hBD-3) and Cathelicidin (LL-37) in a Three-Dimensional Co-Culture Model of Gingival Epithelial Cells and Fibroblasts
Telma Blanca Lombardo Bedran (2014)
10.1016/S0014-5793(99)01520-3
Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK‐lysin
Maria Miteva (1999)
10.1529/BIOPHYSJ.105.062596
Membrane thinning due to antimicrobial peptide binding: an atomic force microscopy study of MSI-78 in lipid bilayers.
A. Mecke (2005)
10.1016/J.COCIS.2013.06.002
Inorganic nanomaterials as delivery systems for proteins, peptides, DNA, and siRNA
M. Malmsten (2013)
10.3390/pharmaceutics5040542
Surface Engineering of Liposomes for Stealth Behavior
Okhil K Nag (2013)
10.3390/molecules181114122
Polymeric Systems of Antimicrobial Peptides—Strategies and Potential Applications
M. Sobczak (2013)
Bioactive Polymeric
R. V. Petersen (1985)
10.1016/j.ejpb.2010.11.010
Geometry and surface characteristics of gold nanoparticles influence their biodistribution and uptake by macrophages.
Arnida (2011)
10.1016/j.bbamem.2008.05.009
Melittin-lipid interaction: a comparative study using liposomes, micelles and bilayer disks.
A. Lundquist (2008)
10.2147/IJN.S109600
Bolaamphiphile-based nanocomplex delivery of phosphorothioate gapmer antisense oligonucleotides as a treatment for Clostridium difficile
J. Hegarty (2016)
10.3389/fphar.2014.00105
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization
Santi M. Mandal (2014)
10.1002/jbm.b.32701
Drug release and bone growth studies of antimicrobial peptide-loaded calcium phosphate coating on titanium.
Mehdi Kazemzadeh-Narbat (2012)
10.1017/S0033583500000123
Electrically gated ionic channels in lipid bilayers.
G. Ehrenstein (1977)
10.1016/j.ijantimicag.2011.07.011
Bioactivity of WLBU2 peptide antibiotic in combination with bioerodible polymer.
J. McClanahan (2011)
10.1016/j.actbio.2010.11.005
Covalent immobilization of antimicrobial peptides (AMPs) onto biomaterial surfaces.
Fabíola Costa (2011)
Polymeric Delivery Systems, Gordon and Breach Science Publishers, New York
H. Ringsdorf (1978)
10.1016/j.biomaterials.2009.07.003
Incorporation of antimicrobial compounds in mesoporous silica film monolith.
I. Izquierdo-Barba (2009)
10.1021/ACS.BIOMAC.6B01452
Conjugation of Polyphosphoester and Antimicrobial Peptide for Enhanced Bactericidal Activity and Biocompatibility.
Dicky Pranantyo (2016)
10.1128/AAC.02624-15
Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis
Eric F Kong (2015)
10.1007/s10989-014-9430-z
Cationic Antimicrobial Peptides Cytotoxicity on Mammalian Cells: An Analysis Using Therapeutic Index Integrative Concept
M. Bacalum (2014)
10.3109/10717544.2014.1003665
Development of an anti-microbial peptide-mediated liposomal delivery system: a novel approach towards pH-responsive anti-microbial peptides
Q. Zhang (2016)
10.1021/BI00019A033
Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore.
K. Matsuzaki (1995)
10.1007/s11095-014-1550-9
Cell-Penetrating Antimicrobial Peptides – Prospectives for Targeting Intracellular Infections
J. S. Bahnsen (2014)
10.1016/J.REACTFUNCTPOLYM.2014.07.008
Biodegradable macromolecular conjugates of citropin: Synthesis, characterization and in vitro efficiency study
M. Sobczak (2014)
Biomed
H. Machado (2013)
10.1016/j.cis.2008.07.007
Characterization and potential applications of nanostructured aqueous dispersions.
A. Yaghmur (2009)
10.1128/AAC.39.2.301
Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin.
S. Haynie (1995)
10.1016/j.bbamem.2012.10.010
Antimicrobial and cell-penetrating properties of penetratin analogs: effect of sequence and secondary structure.
J. S. Bahnsen (2013)
10.1021/acs.langmuir.6b00338
Lipid-Based Liquid Crystals As Carriers for Antimicrobial Peptides: Phase Behavior and Antimicrobial Effect.
Lukas Boge (2016)
10.1016/J.BBAMEM.2006.03.021
Alpha-helical antimicrobial peptides--using a sequence template to guide structure-activity relationship studies.
I. Zelezetsky (2006)
10.1111/J.1432-1033.1995.0257N.X
Functional synergism of the magainins PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes.
H. Westerhoff (1995)
10.1016/j.ijpharm.2014.10.023
Intermolecular interactions between salmon calcitonin, hyaluronate, and chitosan and their impact on the process of formation and properties of peptide-loaded nanoparticles.
A. Umerska (2014)
10.3109/10611869308996088
Liposomal (MLV) polymyxin B: physicochemical characterization and effect of surface charge and drug association.
S. M. Lawrence (1993)
10.1016/J.CANLET.2004.04.006
C-terminal domain of human CAP18 antimicrobial peptide induces apoptosis in oral squamous cell carcinoma SAS-H1 cells.
Kazuhiko Okumura (2004)
10.1016/J.NANO.2005.12.003
Nanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticles.
C. Reis (2006)
10.1016/j.bbamem.2009.08.012
Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR.
A. Ramamoorthy (2010)
10.1007/978-1-4757-0405-1_7
Biodegradable Drug Delivery Systems Based on Polypeptides
Robert V. Petersen (1985)
10.1021/BM049551Y
Functionalized micellar assemblies prepared via block copolymers synthesized by living free radical polymerization upon peptide-loaded resins.
M. Becker (2005)
Biomed
T. Ebenhan (2014)
10.1021/BI0497087
Kinetics of Dye Efflux and Lipid Flip-Flop Induced by δ-Lysin in Phosphatidylcholine Vesicles and the Mechanism of Graded Release by Amphipathic, α-Helical Peptides†
A. Pokorny (2004)
10.1007/978-1-4684-9001-5_15
Polymeric Delivery Systems
R. Langer (1990)
10.1093/JAC/44.5.641
In-vitro activity of cationic peptides alone and in combination with clinically used antimicrobial agents against Pseudomonas aeruginosa.
A. Giacometti (1999)
10.1021/BI960016V
An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation.
K. Matsuzaki (1996)
10.1002/JOR.20511
In vivo release of the antimicrobial peptide hLF1‐11 from calcium phosphate cement
Hein P. Stallmann (2008)
10.1016/0005-2736(95)00087-J
Liposomal entrapment of the neutrophil-derived peptide indolicidin endows it with in vivo antifungal activity.
I. Ahmad (1995)
10.1021/BI9620621
Membrane pores induced by magainin.
S. Ludtke (1996)
10.3390/molecules171012276
Antimicrobial Peptides for Therapeutic Applications: A Review
Min-duk Seo (2012)
10.1016/0169-409X(94)90028-0
Chewing gum as a drug delivery system
M. Rassing (1994)
10.3390/ijms151018040
Novel Formulations for Antimicrobial Peptides
A. M. Carmona-Ribeiro (2014)
10.1371/journal.pone.0012684
Serum Stabilities of Short Tryptophan- and Arginine-Rich Antimicrobial Peptide Analogs
L. T. Nguyen (2010)
10.2147/IJN.S68861
Liposomes as nanomedical devices
G. Bozzuto (2015)
10.3109/02652049509010292
Factors affecting microencapsulation of drugs in liposomes.
S. B. Kulkarni (1995)
10.1021/nn403069n
Effect of polyplex morphology on cellular uptake, intracellular trafficking, and transgene expression.
Julie Shi (2013)
10.1007/978-3-0348-0541-4
Antimicrobial Peptides and Innate Immunity
P. Hiemstra (2013)
10.1002/jbm.b.31381
Synthesis and antibacterial activity of nisin-containing block copolymers.
P. Joshi (2009)
10.3390/molecules20010001
Enzymatic Polymerization of Cyclic Monomers in Ionic Liquids as a Prospective Synthesis Method for Polyesters Used in Drug Delivery Systems
U. Piotrowska (2014)
10.1021/BI026661L
Translocating proline-rich peptides from the antimicrobial peptide bactenecin 7.
Kristen Sadler (2002)
10.1021/cb3005275
Efficient delivery of cyclic peptides into mammalian cells with short sequence motifs.
Ziqing Qian (2013)
10.1038/nrmicro1098
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
K. Brogden (2005)
10.1042/BJ20042138
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity.
I. Zelezetsky (2005)
10.1006/CIMM.1998.1358
Cytotoxicity and apoptosis mediated by two peptides of innate immunity.
A. Risso (1998)
10.1096/fj.03-1459fje
Crotamine is a novel cell‐penetrating protein from the venom of rattlesnake Crotalus durissus terrificus
A. Kerkis (2004)
10.1007/978-1-4939-2285-7_3
Improved methods for classification, prediction, and design of antimicrobial peptides.
G. Wang (2015)
10.5772/58424
Application of Nanotechnology in Drug Delivery
J. Silva (2014)
10.1016/j.plipres.2011.12.005
Role of lipids in the interaction of antimicrobial peptides with membranes.
Vitor Teixeira (2012)
10.1093/JAC/DKG443
Continuous-release or burst-release of the antimicrobial peptide human lactoferrin 1-11 (hLF1-11) from calcium phosphate bone substitutes.
H. P. Stallmann (2003)
10.1016/j.bbamem.2008.09.013
Control of cell selectivity of antimicrobial peptides.
K. Matsuzaki (2009)
10.1074/jbc.M109.036426
A Cell-penetrating Peptide Derived from Human Lactoferrin with Conformation-dependent Uptake Efficiency
Falk Duchardt (2009)
10.1074/JBC.M311440200
The Human Antimicrobial Peptide LL-37 Transfers Extracellular DNA Plasmid to the Nuclear Compartment of Mammalian Cells via Lipid Rafts and Proteoglycan-dependent Endocytosis*
S. Sandgren (2004)
10.1007/s00284-014-0519-6
Antibiofilm and Antimicrobial Efficacy of DispersinB®-KSL-W Peptide-Based Wound Gel Against Chronic Wound Infection Associated Bacteria
P. V. Gawande (2014)
10.1016/j.jconrel.2011.08.029
PEG-stabilized lipid disks as carriers for amphiphilic antimicrobial peptides.
M. Zetterberg (2011)
10.1016/S0014-5793(01)02648-5
Optimization of the antimicrobial activity of magainin peptides by modification of charge
M. Dathe (2001)
10.3390/molecules21010037
Peptide KSL-W-Loaded Mucoadhesive Liquid Crystalline Vehicle as an Alternative Treatment for Multispecies Oral Biofilm
J. Bernegossi (2015)
10.1016/J.JCONREL.2005.05.027
Chewing gum of antimicrobial decapeptide (KSL) as a sustained antiplaque agent: preformulation study.
D. Na (2005)
10.1128/AAC.02542-14
Synergistic Effects of Antimicrobial Peptides and Antibiotics against Clostridium difficile
S. Nuding (2014)
10.1128/CMR.00056-05
Peptide Antimicrobial Agents
H. Jenssen (2006)
10.1080/17425247.2016.1193154
Potential benefits of chewing gum for the delivery of oral therapeutics and its possible role in oral healthcare
S. Wessel (2016)
10.1111/febs.13178
Marine antimicrobial peptide tachyplesin as an efficient nanocarrier for macromolecule delivery in plant and mammalian cells
A. Jain (2015)
10.1016/J.BBAMEM.2006.02.005
Cationic amphipathic histidine-rich peptides for gene delivery.
A. Kichler (2006)
10.1016/S0014-5793(97)00055-0
Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides
M. Dathe (1997)
10.1128/AAC.43.8.2093
In Vitro Activities of Polycationic Peptides Alone and in Combination with Clinically Used Antimicrobial Agents againstRhodococcus equi
A. Giacometti (1999)
10.1128/aac.45.5.1558-1560.2001
Synergistic Interactions between Mammalian Antimicrobial Defense Peptides
H. Yan (2001)
10.2217/17435889.1.3.297
Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential
M. Immordino (2006)
10.1021/MP049974E
An insect antibacterial peptide-based drug delivery system.
L. Otvos (2004)
10.1021/acs.jpclett.6b01622
Antimicrobial Peptide-Driven Colloidal Transformations in Liquid-Crystalline Nanocarriers.
M. Gontsarik (2016)
10.1021/LA702538K
An electrochemical study into the interaction between complement-derived peptides and DOPC mono- and bilayers.
L. Ringstad (2008)
10.1002/POLC.5070510111
Structure and properties of pharmacologically active polymers
H. Ringsdorf (2007)
10.1021/acs.bioconjchem.6b00013
Antibacterial Peptide Nucleic Acid-Antimicrobial Peptide (PNA-AMP) Conjugates: Antisense Targeting of Fatty Acid Biosynthesis.
A. M. Hansen (2016)
10.1038/nrd2591
Strategies in the design of nanoparticles for therapeutic applications
Robby A. Petros (2010)
10.1016/j.jconrel.2014.05.052
Controlling molecular transport and sustained drug release in lipid-based liquid crystalline mesophases.
Alexandru Zabara (2014)
10.1155/2013/387863
Release of a Wound-Healing Agent from PLGA Microspheres in a Thermosensitive Gel
H. A. Machado (2013)
10.1038/71889
Synthetic DNA delivery systems
D. Luo (2000)
10.1016/j.jcis.2010.02.032
Effect of α-helical peptides on liposome structure: a comparative study of melittin and alamethicin.
P. Wessman (2010)
10.1177/0895937409335627
Antimicrobial Peptides for Plaque Control
K. Leung (2009)
10.1016/S0006-2952(02)01346-1
Enhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infection.
Abdelwahab Omri (2002)
10.1016/J.BBRC.2006.08.094
Design and mechanism of action of a novel bacteria-selective antimicrobial peptide from the cell-penetrating peptide Pep-1.
W. Zhu (2006)
10.1016/j.bbamem.2012.08.008
Interaction of gramicidin with DPPC/DODAB bilayer fragments.
C. A. Carvalho (2012)
10.18632/GENESANDCANCER.18
Identification of a novel lytic peptide for the treatment of solid tumours
C. Szczepanski (2014)
10.1016/J.EURURO.2005.12.043
Antitumor activity of the antimicrobial peptide magainin II against bladder cancer cell lines.
J. Lehmann (2006)
10.2174/1568026615666150703121009
Non-Membrane Permeabilizing Modes of Action of Antimicrobial Peptides on Bacteria.
M. Scocchi (2016)
10.1016/S0005-2736(01)00382-0
'Detergent-like' permeabilization of anionic lipid vesicles by melittin.
A. S. Ladokhin (2001)
10.1016/j.ijpharm.2011.05.049
The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems--a review.
S. Fredenberg (2011)
10.1016/J.CLAY.2013.06.003
Adsorption of proteins and nucleic acids on clay minerals and their interactions: A review
W. Yu (2013)
10.1021/JF0348368
Size, stability, and entrapment efficiency of phospholipid nanocapsules containing polypeptide antimicrobials.
L. Were (2003)
10.1016/J.BBAMEM.2007.11.008
Studies on anticancer activities of antimicrobial peptides.
D. Hoskin (2008)
10.1016/S0304-4157(00)00012-5
Surface active drugs: self-association and interaction with membranes and surfactants. Physicochemical and biological aspects.
S. Schreier (2000)
Science Against Pathogens: Communicating Current Research and Technological Advances
C. Cézard (2011)
10.1016/j.clim.2009.12.004
Antimicrobial peptides: general overview and clinical implications in human health and disease.
Eduardo Guaní-Guerra (2010)
10.1016/0378-5173(94)00243-X
Characterization, stability and in vivo targeting of liposomal formulations containing cyclosporin
A. Al-Angary (1995)
10.1074/jbc.M111.303602
Roles of Hydrophobicity and Charge Distribution of Cationic Antimicrobial Peptides in Peptide-Membrane Interactions*
Lois M. Yin (2012)
10.1021/BI00164A017
Interaction of antimicrobial dermaseptin and its fluorescently labeled analogues with phospholipid membranes.
Y. Pouny (1992)
10.1016/S0065-2911(08)60145-9
Cationic bactericidal peptides.
R. Hancock (1995)
10.1128/AAC.00585-12
Intracellular Toxicity of Proline-Rich Antimicrobial Peptides Shuttled into Mammalian Cells by the Cell-Penetrating Peptide Penetratin
A. Hansen (2012)
10.1007/s12026-015-8759-5
An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways
Kazo Kanazawa (2016)
10.1074/jbc.M413406200
Rational Design of α-Helical Antimicrobial Peptides with Enhanced Activities and Specificity/Therapeutic Index*
Yuxin Chen (2005)
10.1155/2013/675391
Antimicrobial Peptides: Versatile Biological Properties
M. Pushpanathan (2013)
FEBS J
B. Fang (2013)
10.1007/BF01569829
Influences on the antimicrobial activity of surface-adsorbed nisin
CK Bower (2005)
10.1016/j.bbamem.2008.10.005
Interaction of an artificial antimicrobial peptide with lipid membranes.
Lanlan Yu (2009)
10.1128/AAC.49.6.2507-2509.2005
In Vitro Activity and Killing Effect of Citropin 1.1 against Gram-Positive Pathogens Causing Skin and Soft Tissue Infections
A. Giacometti (2005)
10.1007/978-3-319-06434-5
Peptide and Protein Interaction with Membrane Systems: Applications to Antimicrobial Therapy and Protein Drug Delivery
S. Bobone (2014)
10.1039/c5pp00038f
Conjugation of photosensitisers to antimicrobial peptides increases the efficiency of photodynamic therapy in cancer cells.
F. Moret (2015)
10.1002/pro.2274
A common landscape for membrane‐active peptides
Nicholas B Last (2013)
10.1155/2014/815981
Cubic and Hexagonal Liquid Crystals as Drug Delivery Systems
Y. Chen (2014)
How to cite this article: Piotrowska U, Sobczak M, Oledzka E. Current state of a dual behaviour of antimicrobial peptides-Therapeutic agents and promising delivery vectors
C Rosés (2012)
10.1016/j.biochi.2011.08.011
Antitumor effects and cell selectivity of temporin-1CEa, an antimicrobial peptide from the skin secretions of the Chinese brown frog (Rana chensinensis).
Che Wang (2012)
10.1016/j.jconrel.2010.11.024
Designing carbohydrate nanoparticles for prolonged efficacy of antimicrobial peptide.
L. Bi (2011)
10.2174/138945012802002302
Nanotools for the delivery of antimicrobial peptides.
Patricia Urban (2012)
10.1166/JBN.2014.1878
Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.
A. Umerska (2014)
10.1529/BIOPHYSJ.104.043596
Interaction of melittin with membrane cholesterol: a fluorescence approach.
H. Raghuraman (2004)
10.1016/j.ijantimicag.2010.08.014
Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.
Y. Liu (2011)
Current state of a dual behaviour of antimicrobial peptides—Therapeutic agents and promising delivery vectors
U Piotrowska (2012)
10.1016/j.ijpharm.2016.02.019
Lipid-based nanoformulations for peptide delivery.
N. Matougui (2016)
10.1002/psc.2894
Short AntiMicrobial Peptides (SAMPs) as a class of extraordinary promising therapeutic agents
S. Ramesh (2016)
10.1021/MZ5001465
Convenient Preparation of Bactericidal Hydrogels by Covalent Attachment of Stabilized Antimicrobial Peptides Using Thiol–ene Click Chemistry
Rik T. C. Cleophas (2014)
10.1046/J.1432-1033.2003.03462.X
nNOS inhibition, antimicrobial and anticancer activity of the amphibian skin peptide, citropin 1.1 and synthetic modifications. The solution structure of a modified citropin 1.1.
Jason R. Doyle (2003)
10.1046/J.1397-002X.2001.10994.X
Determination of stereochemistry stability coefficients of amino acid side-chains in an amphipathic alpha-helix.
Y. Chen (2002)
10.1016/J.TET.2012.02.003
Cell-penetrating γ-peptide/antimicrobial undecapeptide conjugates with anticancer activity
Cristina Rosés (2012)
10.1093/JAC/DKI236
In vitro activity of citropin 1.1 alone and in combination with clinically used antimicrobial agents against Rhodococcus equi.
A. Giacometti (2005)
10.1016/j.ijpharm.2007.11.035
Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains.
M. Alipour (2008)
10.1021/BI9811617
Mechanism of synergism between antimicrobial peptides magainin 2 and PGLa.
K. Matsuzaki (1998)
10.1016/j.ijpharm.2016.04.028
Understanding the adsorption of salmon calcitonin, antimicrobial peptide AP114 and polymyxin B onto lipid nanocapsules.
A. Umerska (2016)
10.1016/j.biomaterials.2016.06.057
Integration of antimicrobial peptides with gold nanoparticles as unique non-viral vectors for gene delivery to mesenchymal stem cells with antibacterial activity.
L. Peng (2016)
10.2147/IJN.S65289
Novel gramicidin formulations in cationic lipid as broad-spectrum microbicidal agents
Danielle Amt Ragioto (2014)
10.1080/17425247.2016.1213239
Sustained-release drug delivery of antimicrobials in controlling of supragingival oral biofilms
D. Steinberg (2017)
10.3389/fimmu.2012.00309
Targeted Antimicrobial Peptides
M. Devocelle (2012)
10.1155/2014/867381
Antimicrobial Peptides: Their Role as Infection-Selective Tracers for Molecular Imaging
T. Ebenhan (2014)
10.1016/j.biochi.2010.02.023
Structural determinants of host defense peptides for antimicrobial activity and target cell selectivity.
D. Takahashi (2010)
10.1128/AEM.61.3.992-997.1995
Suppression of Listeria monocytogenes colonization following adsorption of nisin onto silica surfaces.
C. K. Bower (1995)
10.1007/s00249-011-0682-7
Antimicrobial peptides with cell-penetrating peptide properties and vice versa
Katrin Splith (2011)
10.1016/j.ijpharm.2013.08.035
A novel application of indolicidin for gene delivery.
Wei-Wen Hu (2013)
10.1016/S0014-827X(02)01301-0
PEGylation of the antimicrobial peptide nisin A: problems and perspectives.
A. Guiotto (2003)
10.1021/BI0506371
Permeabilization of raft-containing lipid vesicles by delta-lysin: a mechanism for cell sensitivity to cytotoxic peptides.
A. Pokorny (2005)
Int
M. Pushpanathan (2013)
10.1039/c5nr05577f
RGD-modified lipid disks as drug carriers for tumor targeted drug delivery.
Jie Gao (2016)
10.1111/J.1574-6968.2002.TB11000.X
Role of membranes in the activities of antimicrobial cationic peptides.
R. Hancock (2002)
10.1016/S0022-2836(65)80093-6
Diffusion of univalent ions across the lamellae of swollen phospholipids.
A. Bangham (1965)
10.1038/srep27258
Antimicrobial activity, improved cell selectivity and mode of action of short PMAP-36-derived peptides against bacteria and Candida
Yinfeng Lyu (2016)
10.1371/journal.pone.0126390
Novel Antimicrobial Peptides with High Anticancer Activity and Selectivity
Hung-Lun Chu (2015)



This paper is referenced by
10.2147/IJN.S180040
Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide
Anne-Claire Groo (2018)
10.1002/med.21588
Drug delivery systems designed to overcome antimicrobial resistance
Thanh-Nhat Pham (2019)
10.3390/pharmaceutics11020091
Topological Aspects of the Design of Nanocarriers for Therapeutic Peptides and Proteins
Nadezhda Knauer (2019)
10.3390/polym10050489
A Novel Delivery System for the Controlled Release~of Antimicrobial Peptides: Citropin 1.1 and Temporin A
U. Piotrowska (2018)
10.3390/antibiotics9090625
Figainin 1, a Novel Amphibian Skin Peptide with Antimicrobial and Antiproliferative Properties
Carlos José Correia Santana (2020)
Evaluation du potentiel thérapeutique d'un mannodendrimère anti-inflammatoire dans un modèle murin d'infection par Francisella tularensis
C. Robert (2017)
10.1038/s41573-019-0058-8
Antimicrobial host defence peptides: functions and clinical potential
N. Mookherjee (2020)
10.3390/ijerph15071408
Self-Assembled Antimicrobial Nanomaterials
A. M. Carmona-Ribeiro (2018)
10.3389/fimmu.2020.02177
Innate Inspiration: Antifungal Peptides and Other Immunotherapeutics From the Host Immune Response
D. Mercer (2020)
10.1080/09205063.2018.1504191
Sustained Release of Antimicrobial Peptide from Self-Assembling Hydrogel Enhanced Osteogenesis
Guoli Yang (2018)
10.1039/c9na00693a
Interdependence of charge and secondary structure on cellular uptake of cell penetrating peptide functionalized silica nanoparticles
Isabel Gessner (2020)
[Monoclonal spread of multi-drug resistant CTX-M-15-producing Klebsiella pneumoniae. Impact of measures to control the outbreak].
M. A. Asencio Egea (2018)
10.1002/bip.23097
Insights on the structure‐activity relationship of peptides derived from Sticholysin II
Aline Lima de Oliveira (2018)
10.3389/fcimb.2020.00228
Utilizing Organoid and Air-Liquid Interface Models as a Screening Method in the Development of New Host Defense Peptides
K. Choi (2020)
10.3390/molecules23020329
Role of Cationic Side Chains in the Antimicrobial Activity of C18G
Eric M Kohn (2018)
10.1039/C8TB01408F
The conjugation of indolicidin to polyethylenimine for enhanced gene delivery with reduced cytotoxicity.
Wei-Wen Hu (2018)
10.1039/d0bm00782j
Integration of antimicrobial peptides and gold nanorods for bimodal antibacterial applications.
J. Chen (2020)
10.2217/nnm-2018-0337
A comparison of different strategies for antimicrobial peptides incorporation onto/into lipid nanocapsules.
N. Matougui (2019)
Diseminación monoclonal de Klebsiella pneumoniae productora de CTX-M-15 multirresistente. Impacto de las medidas para controlar el brote
María Ángeles Asencio Egea (2018)
10.3390/molecules25122850
Antimicrobial Peptides as Anticancer Agents: Functional Properties and Biological Activities
Anna Lucia Tornesello (2020)
10.3390/molecules23020311
The Road from Host-Defense Peptides to a New Generation of Antimicrobial Drugs
A. Boto (2018)
10.3390/nano8070482
The Effect of Polymer Microstructure on Encapsulation Efficiency and Release Kinetics of Citropin 1.1 from the Poly(ε-caprolactone) Microparticles
U. Piotrowska (2018)
10.1007/978-981-13-3588-4_7
Antimicrobial and Cell-Penetrating Peptides: How to Understand Two Distinct Functions Despite Similar Physicochemical Properties.
I. Neundorf (2019)
10.1128/AAC.02367-17
The Amphibian Antimicrobial Peptide Temporin B Inhibits In Vitro Herpes Simplex Virus 1 Infection
M. Marcocci (2018)
10.1007/978-3-319-78655-1_23
Humoral Innate Immune Effector Responses
W. Land (2018)
10.3390/molecules25081998
Antimicrobial Peptides as Probes in Biosensors Detecting Whole Bacteria: A Review
Éric Pardoux (2020)
10.1016/j.jconrel.2020.05.002
Formulation technologies and advances for oral delivery of novel nitroimidazoles and antimicrobial peptides.
John Ndayishimiye (2020)
Semantic Scholar Logo Some data provided by SemanticScholar